Affiliation: University of Barcelona, Spain. Task: The ADVANCE TB virtual mobility focuses on a ligand-based drug design strategy to advance hit-to-lead compounds against Mycobacterium abscessus, building on experimental data generated by Dr. T. Martins’ group at the Institute of Research and Innovation in Health (i3S), University of Porto. It strengthened collaboration between the computational team at the University of Barcelona and partners in Portugal, integrating computational and experimental expertise and contributing to ADVANCE TB deliverable D3.1.

Affiliation: Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Spain Task: Elaboration of a general statement between academic clinical sites willing to participate in the ADVANCE-TB Clinical Studies Platform.

Affiliation: i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal. Task: Building a Compound Database for Targeting Mycobacterial Infections.

Affiliation: Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)

Affiliation: Department of Infectious Diseases, Respiratory Medicine and Intensive Care at Charité – Universtitätsmedizin Berlin, Germany

Affiliations: Department of Tuberculosis, Clinical Immunology and Allergy, National Pirogov Memorial Medical University, Vinnytsia, Ukraine. Institut d’Investigació Germans Trias i Pujol (IGTP); Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias. Badalona, Barcelona, Spain